So M J, Cheville J C, Katzmann J A, Riehle D L, Lohse C M, Pankratz V S, Sebo T J
Swarthmore College, Swarthmore, Pennsylvania, USA.
Mod Pathol. 2001 Sep;14(9):906-12. doi: 10.1038/modpathol.3880410.
DNA ploidy and proliferation have been shown in several studies to be prognostic markers for prostate cancer. Flow cytometry (FCM) is often used in the determination of ploidy and proliferation. However, FCM cannot readily distinguish among benign epithelium, stromal and inflammatory cells, high grade prostatic intraepithelial neoplasia (HGPIN), and cancer cells. In this study, we evaluated H&E histologic features of 322 radical prostatectomy formalin-fixed, paraffin-embedded tissue blocks used for determining DNA ploidy, percent S-phase (%S), and %S + %G2M by FCM. The microscopic findings included Gleason score, extent of cancer and HGPIN in the tissue block, and presence of a needle track. The amount of cancer in the block was expressed as a percentage of the total tissue surface area in quartiles: < or =25%, 26-50%, 51-75%, and > or =76%. The extent of HGPIN was recorded in rough 5% intervals. Needle track effect was defined as a combination of fibrohistiocytic reaction, fibrin clot, granuloma formation, and chronic inflammation. The associations between these histologic features and DNA ploidy and proliferation (%S and %S + %G2M) were assessed. In multivariate analyses, Gleason score, the amount of tumor in the tissue block, and the extent of HGPIN were significantly associated with ploidy. Gleason score was the only parameter significantly associated with the proliferation measure of %S. If we included %G2M as part of the proliferative fraction of the histogram, however, both Gleason score and the amount of tumor in the block were significantly associated with this measure of proliferation. The presence of a needle track was not significantly associated with DNA ploidy, %S, or %S + %G2M. In summary, prostate cancer DNA ploidy and proliferation results assessed by FCM in paraffin-embedded tissue blocks were associated with the Gleason score, amount of cancer in the tissue block, and extent of HGPIN. However, the presence of a needle track was not associated with the FCM results.
多项研究表明,DNA倍体和增殖情况是前列腺癌的预后标志物。流式细胞术(FCM)常用于确定倍体和增殖情况。然而,FCM不易区分良性上皮细胞、基质细胞和炎性细胞、高级别前列腺上皮内瘤变(HGPIN)以及癌细胞。在本研究中,我们评估了322个用于通过FCM确定DNA倍体、S期百分比(%S)和%S + %G2M的根治性前列腺切除术福尔马林固定、石蜡包埋组织块的苏木精-伊红(H&E)组织学特征。微观检查结果包括Gleason评分、组织块中癌和HGPIN的范围以及针道的存在情况。组织块中癌的数量以四分位数表示为占总组织表面积的百分比:≤25%、26 - 50%、51 - 75%和≥76%。HGPIN的范围以大致5%的间隔记录。针道效应定义为纤维组织细胞反应、纤维蛋白凝块、肉芽肿形成和慢性炎症的组合。评估了这些组织学特征与DNA倍体和增殖(%S和%S + %G2M)之间的关联。在多变量分析中,Gleason评分、组织块中肿瘤的数量以及HGPIN的范围与倍体显著相关。Gleason评分是与增殖指标%S显著相关的唯一参数。然而,如果我们将%G2M纳入直方图增殖分数的一部分,那么Gleason评分和组织块中肿瘤的数量都与该增殖指标显著相关。针道的存在与DNA倍体、%S或%S + %G2M无显著关联。总之,通过FCM评估石蜡包埋组织块中的前列腺癌DNA倍体和增殖结果与Gleason评分、组织块中癌的数量以及HGPIN的范围相关。然而,针道的存在与FCM结果无关。